Skyrizi 00074-2100-01
Generic: Risankizumab-Rzaa
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 26, 2021
- Listing Expires
- December 31, 2027
- Application
- BLA761105
Need to source Skyrizi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risankizumab | 150 mg/mL |
Drug Class
Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]
Selected Package
00074-2100-01Selected1 SYRINGE in 1 CARTON (0074-2100-01) / 1 mL in 1 SYRINGE
Other packages for this product(1)
1 SYRINGE in 1 CARTON (0074-2100-70) / 1 mL in 1 SYRINGE